D-Glutamate

D-Glutamate

SCHEMBL4393018

CC(C)CC(NC(=O)CCC(N)C(=O)O)C(=O)O.NC(CCC(=O)O)C(=O)O

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 9/20 0.60
NOD1 Q9Y239 5/20 0.55
GRM8 O00222 1/20 0.55
GRM6 O15303 1/20 0.55
GRIN2D O15399 1/20 0.55
GRIN3B O60391 1/20 0.55
GSR P00390 1/20 0.55
CYP1A2 P05177 1/20 0.55
GRIK1 P39086 1/20 0.55
GRM5 P41594 1/20 0.55
GRIA1 P42261 1/20 0.55
GRIA2 P42262 1/20 0.55
GRIA3 P42263 1/20 0.55
SLC1A3 P43003 1/20 0.55
SLC1A2 P43004 1/20 0.55
SLC1A1 P43005 1/20 0.55
GRIA4 P48058 1/20 0.55
GRIN1 Q05586 1/20 0.55
GRIN2A Q12879 1/20 0.55
GRIK2 Q13002 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glutamic Acid SCHEMBL4393021 1.00 FOLH1 (0.60) FOLH1NOD1GRM8GRM6GRIN2D
SCHEMBL234161 0.95 NOD1 (0.58) FOLH1NOD1PTGS1GSTK1ALDH1A1
SCHEMBL9628017 0.95 NOD1 (0.58) FOLH1NOD1PTGS1GSTK1ALDH1A1
SCHEMBL234160 0.95 NOD1 (0.58) FOLH1NOD1PTGS1GSTK1ALDH1A1
SCHEMBL13585297 0.95 NOD1 (0.58) FOLH1NOD1PTGS1GSTK1ALDH1A1
SCHEMBL13585300 0.95 NOD1 (0.58) FOLH1NOD1PTGS1GSTK1ALDH1A1
SCHEMBL30075962 0.93 FOLH1 (0.57) FOLH1NOD1GRM8GRM6GRIN2D
Aspartic Acid SCHEMBL4390861 0.91 NOD1 (0.52) FOLH1NOD1PTGS1GSTK1ALDH1A1
Aspartic Acid SCHEMBL4390865 0.91 NOD1 (0.52) FOLH1NOD1PTGS1GSTK1ALDH1A1
Glutamine SCHEMBL4395724 0.90 KMT2A (0.56) FOLH1NOD1PTGS1GSTK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10175233-B2 Biomarkers for cardiovascular diseases and methods using the same METABOLON, INC. (US) 2019-01-08 US disclosed
US-20160178620-A1 Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and other Metabolic-Syndrome Related Disorders and Methods Using the Same METABOLON, INC. 2016-06-23 US disclosed
US-9250225-B2 Biomarkers for insulin resistance and methods using the same METABOLON, INC. (US) 2016-02-02 US disclosed
US-20150005195-A1 Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and Other Metabolic-Syndrome Related Disorders and Methods Using the Same METABOLON, INC. 2015-01-01 US disclosed
US-8809008-B2 Biomarkers for impaired glucose tolerance and methods using the same METABOLON, INC. (US) 2014-08-19 US disclosed
US-20130338031-A1 Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and Other Metabolic-Syndrome Related Disorders and Methods Using the Same METABOLON, INC. 2013-12-19 US disclosed
EP-2164977-B1 BIOMARKERS FOR PRE-DIABETES AND METHODS USING THE SAME METABOLON INC (US) 2013-10-30 EP disclosed
US-8546098-B2 Biomarkers for monitoring insulin resistance and methods using the same METABOLON, INC. (US) 2013-10-01 US disclosed
US-20120208215-A1 Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and Other Metabolic-Syndrome Related Disorders and Methods Using the Same METABOLON, INC. (US) 2012-08-16 US disclosed
US-8187830-B2 Method for determining insulin sensitivity with biomarkers METABOLON, INC. (US) 2012-05-29 US disclosed
US-20090155826-A1 Biomarkers for pre-diabetes, cardiovascular diseases, and other metabolic-syndrome related disorders and methods using the same METABOLON, INC. (US) 2009-06-18 US disclosed